Amber Kempf at 626-256-6405 or amber.kempf [at] gtcbio.com
Sinclair Research, a preclinical CRO, offers animal efficacy models, IND enabling toxicology services and research capabilities to the human pharmaceutical, animal health and medical device industries. With 20+ years’ experience, Sinclair is the undisputed expert in all breeds of miniswine, we developed and maintain our own research breed, “The Sinclair Pig.”
BioSpherix will be exhibiting the Xvivo System, world’s first and only cytocentric barrier isolator optimized for cells. Economical and practical alternative to cleanrooms for cGMP compliant production of cells for clinical use. Get better contamination, process and quality control. Stop by BioSpherix booth to learn more about the only total quality platform for cells!
Liva Healthcare is a Nordic personal coaching platform designed for those at risk of chronic diseases. A unique hybrid model, Liva connects patients with health professionals via a digital platform. Through setting and monitoring personal goals, this model of technology and human intervention drives long-term behaviour and lifestyle changes.
Crown Bioscience is a cutting edge technology company providing drug discovery services in cardiovascular and metabolic disease, oncology, and inflammation. Our unique rodent and NHP translational platforms replicate the human pre-diabetic state, diabetes progression, and diabetic complications, supporting transition of new antidiabetic agents from lead compounds into the clinic.
Viracor Eurofins provides clinical trial biomarker testing services with expertise in custom assay transfer, design and validation for phase I-IV trials. Our CAP/CLIA and NY state accredited laboratory has over 30 years of experience in molecular testing, immune response monitoring, vaccine safety/efficacy assessment, allergy and hypersensitivity testing.
Merck has a strong history of success in translating cutting-edge research into life-saving medical breakthroughs. We’re pursuing some of the most innovative areas in biomedical research emerging today without regard to therapeutic area/modality. Merck has hundreds of successful collaborations with companies, academic institutions, and other organizations. Learn more at www.merck.com/licensing.
CBSET is a not-for-profit translational research institute specializing in the evaluation of drugs, biotherapeutics, combination products, and medical devices. We provide preclinical services including in-life testing, histopathology and regulatory consulting. Our GLP-compliant facilities host a multidisciplinary team of medical, scientific and regulatory experts who actively collaborate in getting novel technologies to market.
Mercodia is an immunoassay developer in CVD/Metabolism since 1991. We have research-use and FDA-validated immunoassays that meet stringent criteria for moving a therapeutic from research to clinic. We are the gold standard for measuring glucagon, giving researchers tools necessary to identify associations and causal roles for biomarkers in metabolic disease.